Oncolytics Biotech Inc.

03/05/2021 | Press release | Distributed by Public on 03/05/2021 14:47

Fourth Quarter and Year End 2020 Financial Results Conference Call - XBRL

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Cover

Cover

12 Months Ended

Dec. 31, 2020

shares

Cover [Abstract]
Entity Registrant Name ONCOLYTICS BIOTECH INC
Entity Central Index Key 0001129928
Current Fiscal Year End Date --12-31
Entity Filer Category Accelerated Filer
Document Type 20-F
Document Period End Date Dec. 31, 2020
Document Fiscal Year Focus 2020
Document Fiscal Period Focus FY
Amendment Flag false
Entity Common Stock, Shares Outstanding 46,166,980
ICFR Auditor Attestation Flag true
Entity Shell Company false
Entity Emerging Growth Company false
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes